Utilization-driven Revenue GrowthSustained double-digit top-line growth driven by utilization indicates structural demand for high-end oncology services. Higher procedure volumes (including proton fractions +20%+) should allow fixed-cost absorption, support margin expansion as centers scale, and create a multi-quarter runway for recurring revenue.
Improved Leverage And Balance Sheet ResilienceMarked reduction in leverage strengthens financial flexibility for a capital-intensive operator. A lower debt burden and meaningful equity base reduce refinancing pressure, improve covenant headroom, and permit multi-year investments in centers without immediately straining solvency while projects ramp.
Long-term Contractual Stability (Orlando Lease)A multi-year lease extension secures utilization and cash flows from a key proton asset and clarifies end-of-lease options and obligations. This reduces asset-disposition and operational uncertainty, supporting predictable mid-term revenue and making capital planning for other centers more manageable.